These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27747517)

  • 1. Comparative Efficacy of Bisphosphonates to Prevent Fracture in Men with Osteoporosis: A Systematic Review with Network Meta-Analyses.
    Zhou J; Wang T; Zhao X; Miller DR; Zhai S
    Rheumatol Ther; 2016 Jun; 3(1):117-128. PubMed ID: 27747517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Zhou J; Ma X; Wang T; Zhai S
    Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denosumab Versus Bisphosphonates for the Prevention of the Vertebral Fractures in Men with Osteoporosis: An Updated Network Meta-Analysis.
    Li P; Wu X; Li Y; Huang J
    Clin Invest Med; 2022 Sep; 45(3):E14-22. PubMed ID: 36149052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.
    Boonen S; Laan RF; Barton IP; Watts NB
    Osteoporos Int; 2005 Oct; 16(10):1291-8. PubMed ID: 15986101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of pharmacological interventions for osteoporosis in postmenopausal women: a network meta-analysis (Chongqing, China).
    Tan X; Wen F; Yang W; Xie JY; Ding LL; Mo YX
    Menopause; 2019 Aug; 26(8):929-939. PubMed ID: 31021904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis.
    Migliore A; Broccoli S; Massafra U; Cassol M; Frediani B
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):658-67. PubMed ID: 23543450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies.
    Jansen JP; Bergman GJ; Huels J; Olson M
    Curr Med Res Opin; 2009 Aug; 25(8):1861-8. PubMed ID: 19530978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis.
    Nayak S; Greenspan SL
    J Am Geriatr Soc; 2017 Mar; 65(3):490-495. PubMed ID: 28304090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Shi L; Min N; Wang F; Xue QY
    Biomed Res Int; 2019; 2019():2594149. PubMed ID: 31828096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis.
    Sanderson J; Martyn-St James M; Stevens J; Goka E; Wong R; Campbell F; Selby P; Gittoes N; Davis S
    Bone; 2016 Aug; 89():52-58. PubMed ID: 27262775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.
    Iwamoto J; Takeda T; Sato Y
    Expert Opin Pharmacother; 2007 Nov; 8(16):2743-56. PubMed ID: 17956196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures.
    Bianchi G; Sambrook P
    Curr Med Res Opin; 2008 Sep; 24(9):2669-77. PubMed ID: 18694543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg.
    Epstein S; Jeglitsch M; McCloskey E
    Curr Med Res Opin; 2009 Dec; 25(12):2951-60. PubMed ID: 19835464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
    Tadrous M; Wong L; Mamdani MM; Juurlink DN; Krahn MD; Lévesque LE; Cadarette SM
    Osteoporos Int; 2014 Apr; 25(4):1225-35. PubMed ID: 24287510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.
    Kanis JA; Stevenson M; McCloskey EV; Davis S; Lloyd-Jones M
    Health Technol Assess; 2007 Mar; 11(7):iii-iv, ix-xi, 1-231. PubMed ID: 17311734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bisphosphonates treatment in patients with osteoporosis].
    Rizzoli R
    Ther Umsch; 2012 Mar; 69(3):173-81. PubMed ID: 22403110
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.